PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91020F00025DCR IS requesting the services — Leidos Biomedical Research, Inc

Leidos Biomedical Research, Inc holds $2.1B across 186 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 75N91019D00024. Recompete timing centers on the Sep 24, 2028 PoP end — agencies typically plan 12–18 months ahead.

Nih Nci
Awarding office
Department of Health and Human Services (HHS)
Agency
Leidos Biomedical Research, Inc
Recipient
Sep 24, 2028
PoP end
$85.1M
Obligated
541715
NAICS
AN12
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract number75N91020F00025
Also listed as75N91019D00024-75N91020F00025
AgencyDepartment of Health and Human Services (HHS)
Awarding officeNih Nci
IncumbentLeidos Biomedical Research, Inc
UEIHV8BH9BPG8Y9
NAICS541715
PSCAN12
Parent IDIQ / IDV75N91019D00024
Place of performanceFREDERICK, MD
PoP end (current)Sep 24, 2028
Obligated$85.1M

DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEO… is a federal award for Department of Health and Human Services (HHS) held by Leidos Biomedical Research, Inc. Estimated value $97.5M ($85.1M obligated). Current period of performance ends Sep 24, 2028. Place of performance: FREDERICK, MD.

DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR

Recompete timing

Public
● Expiring in 725 days

Current PoP ends Sep 24, 2028 (725 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 24, 2027.

Bonuses end Sept 30

Want the durability read on 75N91020F00025? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Leidos Biomedical Research, Inc — $2.1B obligated across 186 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$2.1B · 100% of firm total
Open full company profile →

Related awards

Same parent · incumbent
75N91020F00026
DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$56.5M
May 25, 2027
75N91022F00007
THIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCIN…
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$38.3M
Sep 29, 2027
75N91021F00013
ENABLING NCI CLINICAL & RESEARCH DATA SHARING
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$92.1M
Feb 28, 2028
75N91020F00009
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW…
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$89.6M
Jul 31, 2028
75N91020F00039
NIAID COVID-19 ACTIV3
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$281.6M
Sep 29, 2029

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75N91020F00025?

75N91020F00025 (DCR IS requesting the services) is a Nih Nci award with an estimated value of $97.5M, currently held by Leidos Biomedical Research, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91020F00025?

Nih Nci awarded 75N91020F00025 to Leidos Biomedical Research, Inc.

Who is the incumbent on 75N91020F00025?

Leidos Biomedical Research, Inc is the incumbent with $2.1B across 186 related awards in SCOUT’s public footprint. The current period of performance ends Sep 24, 2028.

When does Leidos Biomedical Research, Inc’s 75N91020F00025 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 24, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75N91020F00025? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N91020F00025